Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
By A. Cortes, J. Hadler, J. Pointon, P. Robinson, T. Karaderi, P. Leo, K. Cremin, Karena Pryce, J. Harris, Seunghun Lee and 55 more. Nature Genetics, 2013
849 citations recorded by the source corpus.
Ankylosing spondylitis is a common, highly heritable inflammatory arthritis affecting primarily the spine and pelvis. In addition to HLA-B*27 alleles, 12 loci have previously been identified that are associated with ankylosing spondylitis in populations of European ancestry, and 2 associated loci have been identified in Asians. In this study, we used the Illumina Immunochip microarray to perform a case-control association study involving 10,619 individuals with ankylosing spondylitis (cases) and 15,145 controls. We identified 13 new risk loci and 12 additional ankylosing spondylitis–associated haplotypes at 11 loci. Two ankylosing spondylitis–associated regions have now been identified encoding four aminopeptidases that are involved in peptide processing before major histocompatibility complex (MHC) class I presentation. Protective variants at two of these loci are associated both with reduced aminopeptidase function and with MHC class I cell surface expression.
Subfields: Hepatology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/afe3ea49ae30b10031af409ef40ee7ef9901b70c
Citations in the corpus
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013, neutral): “…including increased risk of RA, ankylosing spondylitis and coronary heart disease(asterisks indicate associations obtained from the literature 29,30 ) and protection from asthma, as well as levels of biomarkers (increased C-reactive protein (CRP) and fibrinogen but decreased soluble…”